MYBL2 and breast carcinoma: Furthermore, high levels of B-MYB can predict the probability of breast cancer recurrence and B-MYB is one of 21 genes that were selected for a commercial gene-expression profile test (using RT-PCR) marketed under the brand name Oncotype DX to profile early stage breast cancer [16].